Related Experiment Videos
Direct demonstration that receptor crosslinking or aggregation is important in insulin action
Summary
Antibodies targeting the insulin receptor mimic insulin's effects, but only when they cluster the receptor. Receptor aggregation, not just binding, is key for insulin signaling, independent of cellular structural components.
Area of Science:
- Cell biology
- Endocrinology
- Molecular signaling
Background:
- Antibodies to the insulin receptor can mimic insulin's effects on adipocytes.
- The precise mechanism by which insulin and its receptor interact to elicit cellular responses is complex.
Purpose of the Study:
- To investigate the role of receptor aggregation in mediating insulin-like effects.
- To determine if simple receptor occupancy is sufficient for signal transduction.
Main Methods:
- Utilized antibodies and antibody fragments (bivalent F(ab')(2) and monovalent Fab') against the insulin receptor.
- Measured (125)I-labeled insulin binding and glucose oxidation in adipocytes.
- Investigated the effect of crosslinking antibodies (anti-F(ab')(2) and anti-insulin antibodies) on cellular responses.
- Assessed the impact of microtubule and microfilament disrupting agents.
Main Results:
- Both bivalent and monovalent anti-receptor antibody fragments blocked insulin binding.
- Bivalent fragments retained insulin-like effects (stimulating glucose oxidation), while monovalent fragments did not, acting as antagonists.
- Crosslinking receptor-bound antibodies with secondary antibodies restored insulin-like activity.
- Insulin-like effects were observed even when cytoskeletal structures were disrupted.
Conclusions:
- Receptor aggregation or clustering, not just ligand binding, is necessary for generating insulin-like signals.
- Insulin receptor signaling is independent of microfilaments and microtubules.
- These findings provide insights into the biophysical mechanisms of insulin receptor activation.